Hodgkin lymphoma is one of the most sensitive tumor types to anti-PD-1 inhibition, and this tumor is characterized by an ineffective but rich tumor microenvironment [6,7]. This evidence concerns the gene PDCD1 and Hodgkins lymphoma.